Format

Send to

Choose Destination
PLoS Med. 2014 Apr 8;11(4):e1001616. doi: 10.1371/journal.pmed.1001616. eCollection 2014 Apr.

HIV monoclonal antibodies: a new opportunity to further reduce mother-to-child HIV transmission.

Author information

1
Global HIV Vaccine Enterprise, New York, New York, United States of America.
2
Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Rockville, Maryland, United States of America.
3
Duke University Medical Center, Durham, North Carolina, United States of America.
4
Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
5
Medical Research Council/Uganda Virus Research Institute Uganda Research Unit on AIDS, Entebbe, Uganda.
6
University of Colorado School of Medicine, Denver, Colorado, United States of America.
7
Elizabeth Glaser Pediatric AIDS Foundation, Los Angeles, California, United States of America.
8
Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.

Abstract

Yegor Voronin and colleagues explore how monoclonal antibodies against HIV could provide a new opportunity to further reduce mother-to-child transmission of HIV and propose that new interventions should consider issues related to implementation, feasibility, and access. Please see later in the article for the Editors' Summary.

PMID:
24714363
PMCID:
PMC3979646
DOI:
10.1371/journal.pmed.1001616
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Public Library of Science Icon for PubMed Central
Loading ...
Support Center